SCHEMBL2366396

SCHEMBL2366396

Cc1cc(C2CC2)cnc1N1CCN(C(=O)c2ccc(N3CC(C)OC3=O)cc2N2CCCS2(=O)=O)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 1/20 0.36
KIF18A Q8NI77 2/20 0.35
TOP2B Q02880 1/20 0.33
TP53 P04637 4/20 0.33
MAPT P10636 3/20 0.33
LMNA P02545 3/20 0.33
SLC6A9 P48067 1/20 0.32
SLC6A5 Q9Y345 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAOB P27338 2/20 0.31
MAOA P21397 1/20 0.31
THRB P10828 1/20 0.31
PIK3C3 Q8NEB9 1/20 0.31
PIK3CA P42336 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2366391 1.00 F10 (0.36) F10KIF18ATOP2BTP53MAPT
SCHEMBL2366046 0.91 KIF18A (0.38) F10KIF18ATOP2BTP53MAPT
SCHEMBL2366036 0.91 KIF18A (0.38) F10KIF18ATOP2BTP53MAPT
SCHEMBL2366327 0.88 F10 (0.38) F10KIF18ATOP2BTP53MAPT
SCHEMBL2366319 0.88 F10 (0.38) F10KIF18ATOP2BTP53MAPT
SCHEMBL2367068 0.88 KIF18A (0.35) KIF18ATP53MAPTLMNAKDM4E
SCHEMBL14687209 0.88 TP53 (0.38) KIF18ATP53MAPTLMNASLC6A9
SCHEMBL14703097 0.87 MEN1 (0.41) TP53MAPTLMNAKDM4EALDH1A1
SCHEMBL2366088 0.86 SSTR5 (0.33) F10KIF18ATP53MAPTLMNA
SCHEMBL14687655 0.86 HRH3 (0.34) KIF18ATP53MAPTLMNASLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364975-B1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORP (JP) 2013-06-12 EP disclosed
US-8354401-B2 Oxazolidinone amide aromatic compounds for supressing MMP-9 production MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-01-15 US disclosed
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-10-27 US disclosed
EP-2364975-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE Mitsubishi Tanabe Pharma Corporation (JP) 2011-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MMP9, MMP10, MMP2 F10 346/4885KIF18A 2290/4885TOP2B 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.